SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0001047469-17-001855
Filing Date
2017-03-22
Accepted
2017-03-21 18:07:36
Documents
5
Effectiveness Date
2017-03-22

Document Format Files

Seq Description Document Type Size
1 DEFC14A a2231429zdefc14a.htm DEFC14A 799424
2 G409167.JPG g409167.jpg GRAPHIC 6155
3 G500106.JPG g500106.jpg GRAPHIC 6247
4 G23352BCI001.GIF g23352bci001.gif GRAPHIC 145573
5 G23352BDI001.GIF g23352bdi001.gif GRAPHIC 113850
  Complete submission text file 0001047469-17-001855.txt   1176155
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filed by) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Subject) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A | Act: 34 | File No.: 000-30319 | Film No.: 17705156
SIC: 2834 Pharmaceutical Preparations